Literature DB >> 25549287

The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events.

Sevket Balta1, Cengiz Ozturk.   

Abstract

A full blood count is a routine, inexpensive and easy test that provides information about formed blood contents. The platelet-lymphocyte ratio (PLR) is a novel inflammatory marker, which may be used in many diseases for predicting inflammation and mortality. The PLR can be easily calculated and is widely available but it may be affected by several inflammatory conditions. Recent studies show that a high PLR reflects inflammation, atherosclerosis and platelet activation. More research is needed to determine how the PLR may be used in clinical practice.

Entities:  

Keywords:  Atherosclerosis; inflammation; mortality; platelet-lymphocyte ratio

Mesh:

Substances:

Year:  2014        PMID: 25549287     DOI: 10.3109/09537104.2014.979340

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  45 in total

1.  Inflammatory Conditions in Acute Coronary Syndrome Patients Treated with Percutaneous Coronary Intervention of Saphenous Vein Graft.

Authors:  Tayyar Cankurt; İbrahim E Celik; Selcuk Ozturk; Orhan Maden
Journal:  Int J Angiol       Date:  2020-08-30

2.  The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.

Authors:  Qing Chen; Liu-Xiao Yang; Xue-Dong Li; Dan Yin; Shi-Ming Shi; Er-Bao Chen; Lei Yu; Zheng-Jun Zhou; Shao-Lai Zhou; Ying-Hong Shi; Jia Fan; Jian Zhou; Zhi Dai
Journal:  Tumour Biol       Date:  2015-02-12

3.  Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Praneel Kumar; Stephanie Law; Krishna B Sriram
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

4.  The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.

Authors:  Y Çakıroğlu; F Vural; B Vural
Journal:  J Endocrinol Invest       Date:  2016-03-15       Impact factor: 4.256

5.  Clinical Value of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratio After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Chuanyuan Tao; Jiajing Wang; Xin Hu; Junpeng Ma; Hao Li; Chao You
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

6.  Changes in Perioperative Platelet Lymphocyte Ratio Predict Survival in Oesophago-Gastric Adenocarcinoma.

Authors:  James Tankel; Alexander Calderone; Jose Luis Ramirez Garcia-Luna; Carmen L Mueller; Sarah Najmeh; Jonathan Spicer; David Mulder; Lorenzo Ferri; Jonathan Cools-Lartigue
Journal:  Ann Surg Oncol       Date:  2022-04-04       Impact factor: 5.344

7.  Early Thyroid Volume Reduction in Subacute Thyroiditis Can be a Potential Indicator for Hypothyroidism.

Authors:  Ji Yong Park; Wonsuk Choi; A Ram Hong; Jee Hee Yoon; Hee Kyung Kim; Ho-Cheol Kang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

8.  Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study.

Authors:  Hee Jin Park; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2018-08-07       Impact factor: 2.631

9.  Gestational obesity and subclinical inflammation: The pathway from simple assessment to complex outcome (STROBE-compliant article).

Authors:  Cosmin Rugină; Cristina Oana Mărginean; Lorena Elena Meliţ; Adina Huţanu; Dana Valentina Ghiga; Viviana Modi; Claudiu Mărginean
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

10.  AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects.

Authors:  Carlo De Matteis; Marica Cariello; Giusi Graziano; Stefano Battaglia; Patrizia Suppressa; Giuseppina Piazzolla; Carlo Sabbà; Antonio Moschetta
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.